| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
-Synuclein in Multiple System Atrophy





From the Departments of Pathology,*
Pharmacology,
and
Neurology,
Mayo Clinic Jacksonville,
Jacksonville, Florida; the Department of
Neurology,§
Robert Wood Johnson Medical School,
Piscataway, New Jersey; the Department of
Pathology,¶
Wayne State University, Detroit,
Michigan; and the Departments of Pathology||
and
Neurology,**
University of Michigan, Ann
Arbor, Michigan
Glial cytoplasmic inclusions (GCI) are the hallmark of
multiple system atrophy (MSA), a rare movement disorder
frequently associated with autonomic dysfunction. In this study of 21
cases of MSA, GCI were consistently immunoreactive for
-synuclein and double-immunostained for ubiquitin and
oligodendroglial markers, but not glial fibrillary acidic
protein. No statistically significant difference was found in the
density of GCI in various brain regions in the two forms of
MSA, striatonigral degeneration (SND) and olivopontocerebellar
atrophy (OPCA). Postmortem brain samples from 9 cases of MSA were
fractionated according to solubility in buffer, Triton-X
100, sodium dodecyl sulfate (SDS), and formic
acid, and
-synuclein immunoreactivity was measured in
Western blots. Total
-synuclein immunoreactivity was increased in
MSA compared to controls, with no statistically significant
difference between SND and OPCA. Most of the increase was due to
-synuclein in SDS fractions. In controls this fraction had little or
no immunoreactivity. In 7 cases and 4 controls correlations were
investigated between quantitative neuropathology and biochemical
properties of
-synuclein. Surprisingly, the amount of
SDS-soluble
-synuclein correlated poorly with the number of GCI in
adjacent sections. Furthermore, areas with few or no GCI
unexpectedly had abundant SDS-soluble
-synuclein. These
findings provide evidence that modifications of
-synuclein in MSA
may be more widespread than obvious histopathology.
Moreover, these alterations may constitute a biochemical
signature for the synucleinopathies.
This article has been cited by other articles:
![]() |
J. Tong, H. Wong, M. Guttman, L. C. Ang, L. S. Forno, M. Shimadzu, A. H. Rajput, M. D. Muenter, S. J. Kish, O. Hornykiewicz, et al. Brain {alpha}-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation Brain, January 1, 2010; 133(1): 172 - 188. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakayama, Y. Suzuki, and I. Yazawa Microtubule Depolymerization Suppresses {alpha}-Synuclein Accumulation in a Mouse Model of Multiple System Atrophy Am. J. Pathol., April 1, 2009; 174(4): 1471 - 1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Segarane, A. Li, R. Paudel, S. Scholz, J. Neumann, A. Lees, T. Revesz, J. Hardy, C. J. Mathias, N. W. Wood, et al. GLUCOCEREBROSIDASE MUTATIONS IN 108 NEUROPATHOLOGICALLY CONFIRMED CASES OF MULTIPLE SYSTEM ATROPHY Neurology, March 31, 2009; 72(13): 1185 - 1186. [Full Text] [PDF] |
||||
![]() |
B. F. Boeve, M. H. Silber, C. B. Saper, T. J. Ferman, D. W. Dickson, J. E. Parisi, E. E. Benarroch, J. E. Ahlskog, G. E. Smith, R. C. Caselli, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease Brain, November 1, 2007; 130(11): 2770 - 2788. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. C. Song, D. M.S. Lundvig, Y. Huang, W. P. Gai, P. C. Blumbergs, P. Hojrup, D. Otzen, G. M. Halliday, and P. H. Jensen p25{alpha} Relocalizes in Oligodendroglia from Myelin to Cytoplasmic Inclusions in Multiple System Atrophy Am. J. Pathol., October 1, 2007; 171(4): 1291 - 1303. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. B. Cole, D. D. Murphy, J. Lebowitz, L. Di Noto, R. L. Levine, and R. L. Nussbaum Metal-catalyzed Oxidation of {alpha}-Synuclein: HELPING TO DEFINE THE RELATIONSHIP BETWEEN OLIGOMERS, PROTOFIBRILS, AND FILAMENTS J. Biol. Chem., March 11, 2005; 280(10): 9678 - 9690. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lindersson, D. Lundvig, C. Petersen, P. Madsen, J. R. Nyengaard, P. Hojrup, T. Moos, D. Otzen, W.-P. Gai, P. C. Blumbergs, et al. p25{alpha} Stimulates {alpha}-Synuclein Aggregation and Is Co-localized with Aggregated {alpha}-Synuclein in {alpha}-Synucleinopathies J. Biol. Chem., February 18, 2005; 280(7): 5703 - 5715. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Auluck, M. C. Meulener, and N. M. Bonini Mechanisms of Suppression of {alpha}-Synuclein Neurotoxicity by Geldanamycin in Drosophila J. Biol. Chem., January 28, 2005; 280(4): 2873 - 2878. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ozawa, D. Paviour, N. P. Quinn, K. A. Josephs, H. Sangha, L. Kilford, D. G. Healy, N. W. Wood, A. J. Lees, J. L. Holton, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations Brain, December 1, 2004; 127(12): 2657 - 2671. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. Boeve, M. H. Silber, and T. J. Ferman REM Sleep Behavior Disorder in Parkinson's Disease and Dementia with Lewy Bodies J Geriatr Psychiatry Neurol, September 1, 2004; 17(3): 146 - 157. [Abstract] [PDF] |
||||
![]() |
M. G. Schlossmacher, C. Hamann, A. G. Cole, R. G. Gonzalez, and M. P. Frosch Case 27-2004 - A 79-Year-Old Woman with Disturbances in Gait, Cognition, and Autonomic Function N. Engl. J. Med., August 26, 2004; 351(9): 912 - 922. [Full Text] [PDF] |
||||
![]() |
A. RECCHIA, P. DEBETTO, A. NEGRO, D. GUIDOLIN, S. D. SKAPER, and P. GIUSTI {alpha}-Synuclein and Parkinson's disease FASEB J, April 1, 2004; 18(6): 617 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lindersson, R. Beedholm, P. Hojrup, T. Moos, W. Gai, K. B. Hendil, and P. H. Jensen Proteasomal Inhibition by {alpha}-Synuclein Filaments and Oligomers J. Biol. Chem., March 26, 2004; 279(13): 12924 - 12934. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Lu, Y.-H. Weng, M.-C. Chen, R.-S. Chen, K.-Y. Tzen, S.-P. Wey, G. Ting, H.-C. Chang, and T.-C. Yen 99mTc-TRODAT-1 Imaging of Multiple System Atrophy J. Nucl. Med., January 1, 2004; 45(1): 49 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Pawlyk, B. I. Giasson, D. M. Sampathu, F. A. Perez, K. L. Lim, V. L. Dawson, T. M. Dawson, R. D. Palmiter, J. Q. Trojanowski, and V. M.-Y. Lee Novel Monoclonal Antibodies Demonstrate Biochemical Variation of Brain Parkin with Age J. Biol. Chem., November 28, 2003; 278(48): 48120 - 48128. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Iwata, M. Maruyama, T. Akagi, T. Hashikawa, I. Kanazawa, S. Tsuji, and N. Nukina Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies Hum. Mol. Genet., October 16, 2003; 12(20): 2625 - 2635. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hishikawa, J.-i. Niwa, M. Doyu, T. Ito, S. Ishigaki, Y. Hashizume, and G. Sobue Dorfin Localizes to the Ubiquitylated Inclusions in Parkinson's Disease, Dementia with Lewy Bodies, Multiple System Atrophy, and Amyotrophic Lateral Sclerosis Am. J. Pathol., August 1, 2003; 163(2): 609 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Norris, B. I. Giasson, H. Ischiropoulos, and V. M.-Y. Lee Effects of Oxidative and Nitrative Challenges on {alpha}-Synuclein Fibrillogenesis Involve Distinct Mechanisms of Protein Modifications J. Biol. Chem., July 11, 2003; 278(29): 27230 - 27240. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. Boeve, M. H. Silber, J. E. Parisi, D. W. Dickson, T. J. Ferman, E. E. Benarroch, A. M. Schmeichel, G. E. Smith, R. C. Petersen, J. E. Ahlskog, et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism Neurology, July 8, 2003; 61(1): 40 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Martinez, I. Moeller, H. Erdjument-Bromage, P. Tempst, and B. Lauring Parkinson's Disease-associated alpha -Synuclein Is a Calmodulin Substrate J. Biol. Chem., May 2, 2003; 278(19): 17379 - 17387. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gosavi, H.-J. Lee, J. S. Lee, S. Patel, and S.-J. Lee Golgi Fragmentation Occurs in the Cells with Prefibrillar alpha -Synuclein Aggregates and Precedes the Formation of Fibrillar Inclusion J. Biol. Chem., December 6, 2002; 277(50): 48984 - 48992. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hasegawa, H. Fujiwara, T. Nonaka, K. Wakabayashi, H. Takahashi, V. M.-Y. Lee, J. Q. Trojanowski, D. Mann, and T. Iwatsubo Phosphorylated alpha -Synuclein Is Ubiquitinated in alpha -Synucleinopathy Lesions J. Biol. Chem., December 6, 2002; 277(50): 49071 - 49076. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Fitzmaurice, C. L. Bamsey, L. Ang, M. Guttman, A. H. Rajput, Y. Furukawa, and S. J. Kish Brain aconitase activity is not decreased in progressive supranuclear palsy Neurology, July 9, 2002; 59(1): 137 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. I Golbe Neurodegeneration in the age of molecular biology BMJ, June 22, 2002; 324(7352): 1467 - 1468. [Full Text] [PDF] |
||||
![]() |
H. Miake, H. Mizusawa, T. Iwatsubo, and M. Hasegawa Biochemical Characterization of the Core Structure of alpha -Synuclein Filaments J. Biol. Chem., May 17, 2002; 277(21): 19213 - 19219. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Watanabe, Y. Saito, S. Terao, T. Ando, T. Kachi, E. Mukai, I. Aiba, Y. Abe, A. Tamakoshi, M. Doyu, et al. Progression and prognosis in multiple system atrophy: An analysis of 230 Japanese patients Brain, May 1, 2002; 125(5): 1070 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-H. Ahn, H. Rhim, S. Y. Kim, Y.-M. Sung, M.-Y. Lee, J.-Y. Choi, B. Wolozin, J.-S. Chang, Y. H. Lee, T. K. Kwon, et al. alpha -Synuclein Interacts with Phospholipase D Isozymes and Inhibits Pervanadate-induced Phospholipase D Activation in Human Embryonic Kidney-293 Cells J. Biol. Chem., March 29, 2002; 277(14): 12334 - 12342. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Lee, C. Choi, and S.-J. Lee Membrane-bound alpha -Synuclein Has a High Aggregation Propensity and the Ability to Seed the Aggregation of the Cytosolic Form J. Biol. Chem., January 4, 2002; 277(1): 671 - 678. [Abstract] [Full Text] |
||||
![]() |
D J Burn and E Jaros Multiple system atrophy: cellular and molecular pathology Mol. Pathol., December 1, 2001; 54(6): 419 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Kahle, M. Neumann, L. Ozmen, V. Muller, S. Odoy, N. Okamoto, H. Jacobsen, T. Iwatsubo, J. Q. Trojanowski, H. Takahashi, et al. Selective Insolubility of {alpha}-Synuclein in Human Lewy Body Diseases Is Recapitulated in a Transgenic Mouse Model Am. J. Pathol., December 1, 2001; 159(6): 2215 - 2225. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Perrin, W. S. Woods, D. F. Clayton, and J. M. George Exposure to Long Chain Polyunsaturated Fatty Acids Triggers Rapid Multimerization of Synucleins J. Biol. Chem., November 2, 2001; 276(45): 41958 - 41962. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. I. Giasson, J. E. Duda, I. V. J. Murray, Q. Chen, J. M. Souza, H. I. Hurtig, H. Ischiropoulos, J. Q. Trojanowski, and V. M. -Y. Lee Oxidative Damage Linked to Neurodegeneration by Selective alpha -Synuclein Nitration in Synucleinopathy Lesions Science, November 3, 2000; 290(5493): 985 - 989. [Abstract] [Full Text] |
||||
![]() |
J. E. Duda, B. I. Giasson, Q. Chen, T. L. Gur, H. I. Hurtig, M. B. Stern, S. M. Gollomp, H. Ischiropoulos, V. M.-Y. Lee, and J. Q. Trojanowski Widespread Nitration of Pathological Inclusions in Neurodegenerative Synucleinopathies Am. J. Pathol., November 1, 2000; 157(5): 1439 - 1445. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Galvin, B. Giasson, H. I. Hurtig, V. M.-Y. Lee, and J. Q. Trojanowski Neurodegeneration with Brain Iron Accumulation, Type 1 Is Characterized by {alpha}-, {beta}-, and {gamma}-Synuclein Neuropathology Am. J. Pathol., August 1, 2000; 157(2): 361 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Souza, B. I. Giasson, Q. Chen, V. M.-Y. Lee, and H. Ischiropoulos Dityrosine Cross-linking Promotes Formation of Stable alpha -Synuclein Polymers. IMPLICATION OF NITRATIVE AND OXIDATIVE STRESS IN THE PATHOGENESIS OF NEURODEGENERATIVE SYNUCLEINOPATHIES J. Biol. Chem., June 9, 2000; 275(24): 18344 - 18349. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Iwata, M. Maruyama, I. Kanazawa, and N. Nukina alpha -Synuclein Affects the MAPK Pathway and Accelerates Cell Death J. Biol. Chem., November 21, 2001; 276(48): 45320 - 45329. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |